Volume 13, Number 2—February 2007
Dispatch
Avian Influenza Risk Perception, Europe and Asia
Table 2
Mean score scale 1–10 (95% CI) | |||||
---|---|---|---|---|---|
Country or region | Seriousness, | Vulnerability | Risk perception† | Response efficacy | Self-efficacy |
DNK | 6.08 (5.83–6.33) | 2.82 (2.71–2.92) | 2.73 (2.65–2.81) | 2.32 (2.23–2.41) | 2.15 (2.06–2.24) |
POL | 7.49 (7.29–7.70) | 3.43 (3.31–3.54) | 3.48 (3.39–3.57) | 2.55 (2.46–2.64) | 2.06 (1.96–2.16) |
NLD | 7.67 (7.48–7.87) | 3.17 (3.07–3.27) | 3.40 (3.32–3.48) | 2.25 (2.14–2.35) | 1.74 (1.66–1.83) |
UK | 7.38 (7.16–7.61) | 2.93 (2.81–3.05) | 3.17 (3.07–3.26) | 2.41 (2.32–2.51) | 2.03 (1.93–2.12) |
ESP | 6.76 (6.53–6.99) | 3.43 (3.32–3.53) | 3.29 (3.20–3.37) | 2.75 (2.65–2.85) | 2.26 (2.15–2.36) |
CHN | 6.58 (6.33–6.82) | 2.88 (2.76–2.99) | 2.94 (2.85–3.04) | 2.99 (2.92–3.06) | 2.90 (2.82–2.99) |
HKG | 7.02 (6.81–7.23) | 3.33 (3.23–3.42) | 3.33 (3.25–3.40) | 2.95 (2.87–3.03) | 2.64 (2.55–2.73) |
SGP | 6.63 (6.35–6.91) | 2.70 (2.57–2.83) | 2.82 (2.71–2.93) | 2.81 (2.71–2.91) | 2.70 (2.61–2.80) |
Europe‡ | 7.06 (6.96–7.16) | 3.16 (3.11–3.21) | 3.21 (3.17–3.25) | 2.46 (2.41–2.50) | 2.05 (2.01–2.10) |
Asia | 6.74 (6.60–6.88) | 2.97 (2.90–3.03) | 3.03 (2.97–3.08) | 2.92 (2.87–2.96) | 2.75 (2.69–2.80) |
Total | 6.95 (6.86–7.03) | 3.09 (3.05–3.13) | 3.14 (3.11–3.17) | 2.63 (2.59–2.66) | 2.31 (2.27–2.34) |
*CI, confidence interval; DNK, Denmark; POL, Poland; NLD, the Netherlands; UK, United Kingdom; ESP, Spain; CHN, China; HKG, Hong Kong; SGP, Singapore.
†Square root of the multiplication of seriousness divided by 2 and vulnerability.
‡Differences in mean scores between Europe and Asia are significant for all measures (p<0.001).
Page created: June 29, 2010
Page updated: June 29, 2010
Page reviewed: June 29, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.